JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area epigenetics parp'

Search results for: 'research area epigenetics parp'

A3760 Reversine

Target: Aurora Kinases

Summary: A3 adenosine receptor antagonist,ARK-1/-2/-3 inhibitor

insoluble in H2O; ≥19.65 mg/mL
A4166 EPZ5676

1 Citation

Target: DOT1L

Summary: DOT1L inhibitor,potent and SAM competitive

≥28.15 mg/mL
A4104 AR-42 (OSU-HDAC42)

2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,novel and potent

insoluble in EtOH; insoluble in H2O; ≥15.62 mg/mL
A4114 MLN8054

Target: Aurora Kinases

Summary: Aurora A inhibitor

insoluble in EtOH; insoluble in H2O; ≥39.05 mg/mL
A1907 5-Azacytidine

6 Citation

Target: DNA Methyltransferases

Summary: DNA methyltransferase inhibitor.

insoluble in EtOH; ≥24.45 mg/mL
A1912 Lomeguatrib

Target: O6-methylguanine-DNA-methyl-transferase (MGMT)

Summary: MGMT inhibitor

≥50 mg/mL
A1915 Zebularine

1 Citation

Target: DNA Methyltransferases|Cytidine deaminases

Summary: DNA methylation inhibitor

insoluble in EtOH; ≥50.7 mg/mL
A3214 AZD1152

1 Citation

Target: Aurora Kinases

Summary: Aurora B kinase inhibitor,highly potent and selective

insoluble in H2O; insoluble in EtOH; ≥5.88 mg/mL
A8547 Tubastatin A HCl

1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC6 inhibitor,potent and selective

insoluble in EtOH; ≥12.34 mg/mL
A8178 Panobinostat (LBH589)

10 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥17.47 mg/mL